Onkologisk endokrinologi

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

Algeri, L.; Falkman, Lovisa; Spada, F.; Frassoni, S. et al.

Ingår i ESMO Open, 2024

• DOI för Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers
• Ladda ner fulltext (pdf) av Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Backman, Samuel; Botling, Johan; Nord, Helena; Ghosal, Suman et al.

Ingår i Journal of Pathology, s. 357-370, 2024

• DOI för The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
• Ladda ner fulltext (pdf) av The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT

Boss, Marti; Eriksson, Olof; Mikkola, Kirsi; Eek, Annemarie et al.

Ingår i Journal of Nuclear Medicine, s. 1959-1964, 2024

• DOI för Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT
• Ladda ner fulltext (pdf) av Improved Localization of Insulinomas Using ⁶⁸Ga-NODAGA-Exendin-4 PET/CT

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Falkman, Lovisa; Sundin, Anders; Skogseid, Britt; Botling, Johan et al.

Ingår i Upsala Journal of Medical Sciences, 2024

• DOI för Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
• Ladda ner fulltext (pdf) av Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Hadoux, J.; Lamarca, A.; Grande, E.; Deandreis, D. et al.

Ingår i ESMO Open, 2024

• DOI för Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5
• Ladda ner fulltext (pdf) av Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Lamarca, Angela; Bartsch, Detlef K.; Caplin, Martyn; Kos‐Kudla, Beata et al.

Ingår i Journal of neuroendocrinology, 2024

• DOI för European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Papantoniou, Dimitrios; Fröss-Baron, Katarzyna; Garske Roman, Ulrike; Sundin, Anders et al.

Ingår i Journal of neuroendocrinology, 2024

• DOI för Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
• Ladda ner fulltext (pdf) av Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Ingår i Journal of neuroendocrinology, 2024

• DOI för Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
• Ladda ner fulltext (pdf) av Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer

Asowed, Mustafa; Elander, Nils O.; Pettersson, Linn; Ekholm, Maria et al.

Ingår i BMC Cancer, 2023

• DOI för Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
• Ladda ner fulltext (pdf) av Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Dam, Gitte; Grønbæk, Henning; Sundlöv, Anna; Botling, Johan et al.

Ingår i Acta Oncologica, s. 431-437, 2023

• DOI för Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

Kjaer, Josefine; Smith, Sara; Hellman, Per; Stålberg, Peter et al.

Ingår i World Journal of Surgery, s. 340-347, 2023

• DOI för Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
• Ladda ner fulltext (pdf) av Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Papantoniou, Dimitrios; Grönberg, Malin; Thiis-Evensen, Espen; Sorbye, Halfdan et al.

Ingår i Endocrine-Related Cancer, 2023

• DOI för Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
• Ladda ner fulltext (pdf) av Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Sorbye, Halfdan; Grande, Enrique; Pavel, Marianne; Tesselaar, Margot et al.

Ingår i Journal of neuroendocrinology, 2023

• DOI för European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma
• Ladda ner fulltext (pdf) av European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Almeamar, Hussein; Cullen, Lisa; Murphy, David J.; Crowley, Rachel K. et al.

Ingår i Journal of neuroendocrinology, 2022

• DOI för Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Bruhn-Olszewska, Bozena; Davies, Hanna; Sarkisyan, Daniil; Juhas, Ulana et al.

Ingår i Genome Medicine, 2022

• DOI för Loss of Y in leukocytes as a risk factor for critical COVID-19 in men
• Ladda ner fulltext (pdf) av Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study

Hörsch, Dieter; Anthony, Lowell; Gross, David J.; Valle, Juan et al.

Ingår i Neuroendocrinology, s. 298-309, 2022

• DOI för Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study
• Ladda ner fulltext (pdf) av Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Kjaer, Josefin; Clancy, Thomas E.; Thornell, Anders; Andersson, Niklas et al.

Ingår i Annals of Surgery Open, 2022

• DOI för Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
• Ladda ner fulltext (pdf) av Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Ingår i Endocrine Connections, 2022

• DOI för Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
• Ladda ner fulltext (pdf) av Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels

Sundblom, Jimmy; Persson Skare, Tor; Holm, Olivia; Welin, Staffan et al.

Ingår i PLOS ONE, 2022

• DOI för Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels
• Ladda ner fulltext (pdf) av Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels

Systemic treatment in patients with malignant pleural mesothelioma - real life experience

Ziolkowska, Barbara; Cybulska-Stopa, Bozena; Papantoniou, Dimitrios; Suwinski, Rafal

Ingår i BMC Cancer, 2022

• DOI för Systemic treatment in patients with malignant pleural mesothelioma - real life experience
• Ladda ner fulltext (pdf) av Systemic treatment in patients with malignant pleural mesothelioma - real life experience

Taxane-induced pain in breast cancer patients as perceived by nurses

Borjesson, Susanne; Nordin, Karin; Fjällskog, Marie-Louise; Peterson, Magnus et al.

Ingår i Acta Oncologica, s. 412-418, 2021

• DOI för Taxane-induced pain in breast cancer patients as perceived by nurses

Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome

Dillon, Joseph S.; Kulke, Matthew H.; Hörsch, Dieter; Anthony, Lowell B. et al.

Ingår i Journal of Gastrointestinal Cancer, s. 212-221, 2021

• DOI för Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
• Ladda ner fulltext (pdf) av Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Ingår i Neuroendocrinology, s. 883-894, 2021

• DOI för A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Ingår i Neuroendocrinology, s. 330-343, 2021

• DOI för 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Ladda ner fulltext (pdf) av 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Jawlakh, Hiba; Velikyan, Irina; Welin, Staffan; Sundin, Anders

Ingår i Journal of neuroendocrinology, 2021

• DOI för Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging
• Ladda ner fulltext (pdf) av Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

Kjaer, Josefin; Stålberg, Peter; Crona, Joakim; Welin, Staffan et al.

Ingår i BJS Open, 2021

• DOI för Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases
• Ladda ner fulltext (pdf) av Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors

Kjellman, Magnus; Knigge, Ulrich; Welin, Staffan; Thiis-Evensen, Espen et al.

Ingår i Neuroendocrinology, s. 840-849, 2021

• DOI för A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors

Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Lase, Ieva; Grönberg, Malin; Norlén, Olov; Stålberg, Peter et al.

Ingår i Journal of neuroendocrinology, 2021

• DOI för Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Papantoniou, Dimitrios; Grönberg, Malin; Landerholm, Kalle; Welin, Staffan et al.

Ingår i Endocrine, s. 893-904, 2021

• DOI för Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
• Ladda ner fulltext (pdf) av Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Pommergaard, Hans-Christian; Nielsen, Kirstine; Sorbye, Halfdan; Federspiel, Birgitte et al.

Ingår i Journal of neuroendocrinology, 2021

• DOI för Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Tiensuu Janson, Eva; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte et al.

Ingår i Acta Oncologica, s. 931-941, 2021

• DOI för Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
• Ladda ner fulltext (pdf) av Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Ingår i PLOS ONE, 2020

• DOI för PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
• Ladda ner fulltext (pdf) av PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Ingår i Scientific Reports, 2020

• DOI för Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
• Ladda ner fulltext (pdf) av Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Botling, Johan; Lamarca, Angela; Bajic, Duska; Norlén, Olov et al.

Ingår i Neuroendocrinology, s. 891-898, 2020

• DOI för High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Dam, Gitte; Gronbaek, Henning; Sorbye, Halfdan; Evensen, Espen Thiis et al.

Ingår i Neuroendocrinology, s. 217-224, 2020

• DOI för Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

Juhlin, Carl Christofer; Falhammar, Henrik; Kjellman, Magnus; Ahlen, Jan et al.

Ingår i BMC Gastroenterology, 2020

• DOI för Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission
• Ladda ner fulltext (pdf) av Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Lase, Ieva; Strele, Ieva; Grönberg, Malin; Kozlovacki, Gordana et al.

Ingår i Hormones, s. 351-360, 2020

• DOI för Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
• Ladda ner fulltext (pdf) av Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms

Baudin, Eric; Hayes, Aimee R.; Scoazec, Jean-Yves; Filosso, Pier Luigi et al.

Ingår i Neuroendocrinology, s. 7-17, 2019

• DOI för Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms

Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms

Capdevila, Jaume; Bodei, Lisa; Davies, Philippa; Gorbounova, Vera et al.

Ingår i Neuroendocrinology, s. 18-25, 2019

• DOI för Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Carlsen, Esben Andreas; Fazio, Nicola; Granberg, Dan; Grozinsky-Glasberg, Simona et al.

Ingår i Endocrine-Related Cancer, s. 227-239, 2019

• DOI för Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Georgantzi, Kleopatra; Sköldenberg, Erik; Tiensuu Janson, Eva; Jakobson, Åke et al.

Ingår i Journal of Pediatric Surgery, s. 1253-1256, 2019

• DOI för Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V.; Jakobson, Åke; Christofferson, Rolf et al.

Ingår i Endocrine pathology, s. 173-179, 2019

• DOI för Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma
• Ladda ner fulltext (pdf) av Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Bronchial carcinoids

Granberg, Dan

Ingår i INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019

• DOI för Bronchial carcinoids
• Ladda ner fulltext (pdf) av Bronchial carcinoids

Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms

Jensen, Robert T.; Bodei, Lisa; Capdevila, J.; Couvelard, Anne et al.

Ingår i Neuroendocrinology, s. 26-36, 2019

• DOI för Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms

Colorectal Neuroendocrine Neoplasms - areas of unmet need

Ramage, John K; Valle, Juan; Nieveen van Dijkum, Els J M; Sundin, Anders et al.

Ingår i Neuroendocrinology, s. 45-53, 2019

• DOI för Colorectal Neuroendocrine Neoplasms - areas of unmet need

Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Sorbye, Halfdan; Baudin, Eric; Borbath, Ivan; Caplin, Martyn et al.

Ingår i Neuroendocrinology, s. 54-62, 2019

• DOI för Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Toumpanakis, Christos; Fazio, Nicola; Tiensuu Janson, Eva; Hörsch, Dieter et al.

Ingår i Neuroendocrinology, s. 37-44, 2019

• DOI för Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Granberg, Dan et al.

Ingår i Cancers, 2019

• DOI för Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.
• Ladda ner fulltext (pdf) av Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Ali, Abir A.; Grönberg, Malin; Hjortland, G. O.; Grønbæk, H. et al.

Ingår i Neuroendocrinology, s. 184-184, 2018

• DOI för Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Ingår i Medical Oncology, 2018

• DOI för Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
• Ladda ner fulltext (pdf) av Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)